Deutsche Bank Ag\ Royalty Pharma PLC Transaction History

Deutsche Bank Ag\

$262 Billion
Q2 2025

A detailed history of Deutsche Bank Ag\ transactions in Royalty Pharma PLC stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,751,252 shares of RPRX stock, worth $62.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,751,252

Previous 1,414,926 23.77%

Holding current value

$62.8 Million

Previous $44 Million 43.25%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$30.85 - $36.14 $10.4 Million - $12.2 Million	336,326 Added 23.77%	1,751,252 $63.1 Million
Q1 2025 May 09, 2025	SELL	$25.75 - $33.86 $45.7 Million - $60.1 Million	-1,775,038 Reduced 55.64%	1,414,926 $44 Million
Q4 2024 Jun 30, 2025	BUY	$24.28 - $28.39 $43.1 Million - $50.4 Million	1,775,038 Added 125.45%	3,189,964 $81.4 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $20.6 Million - $24.1 Million	847,704 Added 36.19%	3,189,964 $81.4 Million
Q3 2024 Jun 26, 2025	BUY	$25.63 - $29.27 $23.8 Million - $27.1 Million	927,334 Added 65.54%	2,342,260 $66.3 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $34.9 Million - $39.9 Million	1,362,476 Added 139.06%	2,342,260 $66.3 Million
Q2 2024 Jun 12, 2025	SELL	$26.26 - $29.9 $11.4 Million - $13 Million	-435,142 Reduced 30.75%	979,784 $25.8 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $10.8 Million - $12.3 Million	410,590 Added 72.14%	979,784 $25.8 Million
Q1 2024 Jun 02, 2025	SELL	$27.46 - $31.33 $23.2 Million - $26.5 Million	-845,732 Reduced 59.77%	569,194 $17.3 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $334,709 - $381,881	12,189 Added 2.19%	569,194 $17.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $1.62 Million - $1.8 Million	61,764 Added 12.47%	557,005 $15.6 Million
Q3 2023 Nov 09, 2023	SELL	$26.26 - $31.38 $9.22 Million - $11 Million	-350,974 Reduced 41.48%	495,241 $13.4 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $9.27 Million - $11.4 Million	313,151 Added 58.75%	846,215 $26 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $2.46 Million - $2.96 Million	-75,001 Reduced 12.33%	533,064 $19.2 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $4.66 Million - $5.24 Million	119,004 Added 24.33%	608,065 $24 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $1.24 Million - $1.39 Million	31,101 Added 6.79%	489,061 $19.7 Million
Q2 2022 Aug 11, 2022	SELL	$37.53 - $44.22 $17,113 - $20,164	-456 Reduced 0.1%	457,960 $19.3 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $1.02 Million - $1.16 Million	27,320 Added 6.34%	458,416 $17.9 Million
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $4.05 Million - $4.89 Million	115,190 Added 36.46%	431,096 $17.2 Million
Q3 2021 Nov 04, 2021	BUY	$36.14 - $42.24 $2.6 Million - $3.04 Million	71,998 Added 29.52%	315,906 $11.4 Million
Q2 2021 Aug 11, 2021	BUY	$39.85 - $46.63 $2.71 Million - $3.18 Million	68,124 Added 38.75%	243,908 $10 Million
Q1 2021 May 13, 2021	SELL	$42.34 - $52.82 $1.78 Million - $2.22 Million	-41,943 Reduced 19.26%	175,784 $7.67 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $7.8 Million - $10.8 Million	215,925 Added 11982.52%	217,727 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $69,485 - $87,144	1,802 New	1,802 $76,000

Others Institutions Holding RPRX

# of Institutions

496

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account